Hoffman v. Secretary of Health and Human Services

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

********************** DUANE HOFFMAN, *

* No. 19-111V Petitioner, * Special Master Christian J. Moran

* v. *

* Filed: September 13, 2024 SECRETARY OF HEALTH * AND HUMAN SERVICES, *

* Respondent. *

********************** Isaiah Kalinowski, Bosson Legal Group, P.C., Fairfax, VA, for petitioner; Felicia D. Langel, United States Dep’t of Justice, Washington, DC, for respondent.

RULING FINDING ENTITLEMENT TO COMPENSATION 1 Duane Hoffman alleges that an influenza (“flu”) vaccine caused him to develop a neurologic problem, chronic inflammatory demyelinating polyneuropathy (“CIDP”). Mr. Hoffman supported his claim with reports from a neurologist retained for this litigation, Zurab Nadareishvili. The Secretary disputes Mr. Hoffman’s claim that the flu vaccine injured him and has, likewise, supported his position with reports from a neurologist the Secretary retained for this litigation, Michael Wilson.

An Initial Entitlement Decision rejected Mr. Hoffman’s argument that he was required to present a plausible theory of how the flu vaccine can cause CIDP. Initial Entitlement Decision, issued Jan. 10, 2024, 2024 WL 402731. Mr. Hoffman contested this determination. Pet’r’s Mot. for Rev., filed Feb. 9, 2024. The Court agreed that the Initial Entitlement Decision erroneously elevated Mr. Hoffman’s burden of proof. Opinion and Order, issued July 8, 2024, 2024 WL 3688477. The Court remanded for further adjudication.

Upon remand, the parties filed supplemental briefs. An oral argument with the undersigned was held on August 16, 2024.2 A review of the evidence under the Court’s standards shows that Mr. Hoffman is entitled to compensation. I. Background3

Mr. Hoffman was born in 1960. For many years, he worked as a corrections officer, although he was not employed when he received the allegedly causal flu vaccination in 2017. Exhibit 23 (affidavit regarding damages).

More than two years before the flu vaccination, Mr. Hoffman was diagnosed with chronic lymphocytic leukemia (“CLL”). Exhibit 10 at 7 (Mar. 31. 2015). The Secretary’s expert, Dr. Wilson, has proposed that the leukemia is associated with an increased risk for CIDP. Exhibit A at 5.

In January 2017, Mr. Hoffman was hospitalized due to an exacerbation of chronic obstructive pulmonary disease. Exhibit 4 at 657. While hospitalized, Mr. Hoffman received the flu vaccine. Exhibit 1. (Mr. Hoffman also received a pneumococcal vaccine but his claim rests upon the flu vaccine.)

Mr. Hoffman was diagnosed with low back pain on January 24, 2017. Exhibit 4 at 819, 862. This pain continued and Mr. Hoffman developed other problems for which he was admitted to Riverside Methodist Hospital. In Riverside Methodist Hospital, Mr. Hoffman underwent tests, including an EMG/NCS. Based upon the results, Mr. Hoffman’s doctors diagnosed him with a neurologic disorder, Guillain-Barré syndrome. Exhibit 7 at 261, 876-81.

Guillain-Barré syndrome is: (i) … an acute monophasic peripheral neuropathy that encompasses a spectrum of four clinicopathological subtypes described below. For each subtype of GBS, the interval between the first appearance of symptoms and the nadir of weakness is between 12 hours and 28 days. This is followed in all subtypes by a clinical plateau with stabilization at the nadir of symptoms, or subsequent improvement without significant relapse. Death may occur without a clinical plateau. Treatment related fluctuations in all subtypes of GBS can occur within 9 weeks of GBS symptom onset and recurrence of symptoms after this time-frame would not be consistent with GBS. (ii) The most common subtype in North America and Europe, comprising more than 90 percent of cases, is acute inflammatory demyelinating polyneuropathy (AIDP), which has the pathologic and electrodiagnostic features of focal demyelination of motor and sensory peripheral nerves and nerve roots. . . . AIDP [is] typically characterized by symmetric motor flaccid weakness, sensory abnormalities, and/or autonomic dysfunction caused by autoimmune damage to peripheral nerves and nerve roots. The diagnosis of AIDP. . . requires:

(A) Bilateral flaccid limb weakness and decreased or absent deep tendon reflexes in weak limbs; (B) A monophasic illness pattern; (C) An interval between onset and nadir of weakness between 12 hours and 28 days; (D) Subsequent clinical plateau (the clinical plateau leads to either stabilization at the nadir of symptoms, or subsequent improvement without significant relapse; however, death may occur without a clinical plateau); and, (E) The absence of an identified more likely alternative diagnosis.

***

(v) To qualify as any subtype of GBS, there must not be a more likely alternative diagnosis for the weakness. (vi) Exclusionary criteria for the diagnosis of all subtypes of GBS include the ultimate diagnosis of any of the following conditions: chronic immune demyelinating polyradiculopathy (CIDP) . . .

42 C.F.R. § 100.3(c)(15).

Mr. Hoffman’s doctors prescribed a standard treatment for GBS, the infusion of intravenous immunoglobulin (“IVIG”). In early 2017, when Mr. Hoffman’s doctors were treating him for GBS, at least one doctor stated that the flu vaccine caused Mr. Hoffman’s GBS. Exhibit 7 at 266; see also Exhibit 4 at 1053 (note, from an unknown source, that Mr. Hoffman’s allergies include the flu vaccine).

Mr. Hoffman attempted rehabilitation for several months and sought care from various doctors. One neurologist, Geoffrey Eubank, ordered a test for anti- ganglioside antibodies. The results were negative. Exhibit 9 at 32.

Approximately eight months after the diagnosis of GBS, Mr. Hoffman saw Dr. Eubank again. Exhibit 19 at 66 (Oct. 9, 2017). Dr. Eubank changed the diagnosis to CIDP. He explained his rationale. Dr. Eubank previously thought that [Mr. Hoffman] had Guillain Barre syndrome but . . . [h]e continued to have some worsening this summer and subsequently improved with a course of IVIG for 5 days. This would not be typical for Guillain Barre which should be more of a monophasic illness.

Id.

Another neurologist, Timothy Rust, confirmed the diagnosis of CIDP. Exhibit 19 at 58 (Dec. 13, 2017). Dr. Rust wrote that “CLL can be associated with peripheral nervous system pathology similar to non-Hodgkin lymphoma, including a relatively high rate of CIDP.” Id.

The diagnosis of CIDP is accepted by the neurologists retained to provide opinions. Exhibit 30 at 7; Exhibit A at 3-4. 4 “CIDP” stands for “chronic inflammatory demyelinating polyneuropathy,” which explains the basic information about the disease. See Exhibit A at 4. Although most cases of CIDP develop insidiously, CIDP can develop abruptly as in Mr. Hoffman’s case. Exhibit 30 at 7, Exhibit A at 4.

As discussed below, the etiology of CIDP is “poorly understood.” Exhibit A at 5. According to Dr. Nadareishvili, “An abundance of clinical and experimental research has led to the conclusion that CIDP is mediated by humoral and cellular immunity against Schwann cell/myelin target antigens in the nerves, thus its classification as an autoimmune disease.” Exhibit 30 at 9. A primary question in this litigation is whether the flu vaccine can provoke an autoimmune attack, which leads to CIDP.

II. Procedural History5

Initially, Mr. Hoffman alleged that the flu vaccine caused him to suffer GBS. Pet., filed Jan. 22, 2019, ¶ 15. He sought compensation via the Vaccine Injury Table and adjudication through the special processing unit of the Office of Special Masters. Id. ¶ 20-21. The case was assigned to the special processing unit. Mr. Hoffman periodically filed medical records.

The Secretary reviewed the evidence and recommended that compensation be denied. Resp’t’s Rep., filed June 12, 2020. The Secretary maintained that based upon the records from Dr. Eubank and Dr. Rust, Mr. Hoffman suffered from CIDP, not GBS. Id. at 8. Because resolution through the special processing unit seemed infeasible, the case was reassigned. Notice, issued June 25, 2020.

Mr. Hoffman changed his claim. He alleged that the flu vaccine was the cause-in-fact of his CIDP. Am. Pet., filed Sep. 17, 2020.

Mr. Hoffman supported his claim that the flu vaccine caused his CIDP with a report from Dr. Nadareishvili. Exhibit 30. Dr. Nadareishvili stated that CIDP is similar to GBS. He proposed that the flu vaccine can cause CIDP via molecular mimicry. Id. at 7-16.

The Secretary countered by presenting a report from Dr. Wilson. Exhibit A. Dr. Wilson disputed molecular mimicry as a theory to explain how a flu vaccine might cause CIDP. Id. at 4-5. Dr. Wilson noted that to the extent that molecular mimicry might predict an attack on gangliosides as causing CIDP, this theory would not explain what happened to Mr. Hoffman because a test for anti- ganglioside antibodies was negative. Id. at 5. Finally, Dr. Wilson suggested that chronic lymphocytic leukemia is associated with CIDP. Id. at 5.

Dr. Nadareishvili responded to Dr. Wilson in a report filed on January 11, 2022. Exhibit 63. Dr. Nadareishvili contended that Dr. Wilson did not explain how CLL can cause CIDP. Id. at 3.

Dr. Wilson replied that he did not say that CLL can cause CIDP because “No one knows what triggers CIDP.” Exhibit C at 2 (filed Mar. 14, 2022). In an ensuing status conference, the Secretary was asked how Mr. Hoffman’s chronic lymphocytic leukemia affects the case given that Dr. Wilson has not presented any mechanism by which CLL can cause CIDP. The Secretary stated that he might obtain a report from a different expert and Mr. Hoffman objected to adding a new expert on the ground that Mr. Hoffman’s CLL had been in the record. The Secretary eventually reported that he was not interested in settlement and will continue to defend the case. Resp’t’s Status Rep., filed Apr. 27, 2022.

The parties were directed to file briefs. Order, issued July 18, 2022. Mr. Hoffman filed his primary brief on August 22, 2022 and his reply on October 5, 2022. In between, the Secretary filed his brief on September 21, 2022.

As noted previously, Mr. Hoffman was found not entitled to compensation. Initial Entitlement Decision. 2024 WL 402731. The basis for denial was two-fold. First, the appropriate burden of proof regarding Althen prong 1 is preponderant evidence, not plausibility. Second, Mr. Hoffman failed to establish the persuasiveness of the molecular mimicry theory in the context of a flu vaccine causing CIDP. The Initial Entitlement Decision also commented, briefly, on Althen prong 2 and Althen prong 3. The Initial Entitlement Decision found that Mr. Hoffman had likely established Althen prong 3 because the interval between the vaccination and the onset of his CIDP was appropriate for inferring causation. However, the evidence regarding Althen prong 2 was less clear.

In granting Mr. Hoffman’s motion for review, the Court focused upon the burden of proof for Althen prong 1. The Court instructed the undersigned to determine whether Mr. Hoffman “has presented preponderant evidence linking the flu vaccine to CIDP via a biologically plausible theory.” Opinion and Order, 2024 WL 3688477, at *14. Earlier, the Opinion and Order had defined “plausibility” as “a qualitative inquiry into whether a fact is ‘[c]onceivably true.’” Id. at *2 n.1 (quoting Black’s Law Dictionary (11th ed. 2019)).

Following remand, the parties were directed to answer various questions and they did. See Order, issued July 9, 2024; Pet’r’s Br. on Remand, filed July 24, 2024; Resp’t’s Br. on Remand, filed July 24, 2024. An oral argument was held on August 16, 2024. With the oral argument, the case is again ready for adjudication. III. Standards for Adjudication

A petitioner is required to establish his case by a preponderance of the evidence. 42 U.S.C. § 300aa–13(1)(a). The preponderance of the evidence standard requires a “trier of fact to believe that the existence of a fact is more probable than its nonexistence before [he] may find in favor of the party who has the burden to persuade the judge of the fact's existence.” Moberly v. Sec’y of Health & Hum. Servs., 592 F.3d 1315, 1322 n.2 (Fed. Cir. 2010) (citations omitted). Proof of medical certainty is not required. Bunting v. Sec’y of Health & Hum. Servs., 931 F.2d 867, 873 (Fed. Cir. 1991).

Distinguishing between “preponderant evidence” and “medical certainty” is important because a special master should not impose an evidentiary burden that is too high. Andreu v. Sec’y of Health & Hum. Servs., 569 F.3d 1367, 1379-80 (Fed. Cir. 2009) (reversing special master's decision that petitioners were not entitled to compensation); see also Lampe v. Sec’y of Health & Hum. Servs., 219 F.3d 1357 (Fed. Cir. 2000); Hodges v. Sec’y of Health & Hum. Servs., 9 F.3d 958, 961 (Fed. Cir. 1993) (disagreeing with dissenting judge's contention that the special master confused preponderance of the evidence with medical certainty).

When a petitioner, like Mr. Hoffman, claims that a vaccine caused an injury not listed on the Vaccine Injury Table, such as CIDP, the elements of a petitioner’s case are well defined. A petitioner bears a burden “to show by preponderant evidence that the vaccination brought about [the vaccinee’s] injury by providing: (1) a medical theory causally connecting the vaccination and the injury; (2) a logical sequence of cause and effect showing that the vaccination was the reason for the injury; and (3) a showing of a proximate temporal relationship between vaccination and injury.” Althen v. Sec’y of Health & Hum. Servs., 418 F.3d 1274, 1278 (Fed. Cir. 2005).

The contents of the Opinion and Order are binding in this case. Boatmon v. Sec’y of Health & Hum. Servs., 941 F.3d 1351, 1358 (Fed. Cir. 2019). In the context of evaluating a district court's actions after a remand, the Federal Circuit has stated that “the district court's actions on remand should not be inconsistent with either the letter or the spirit of the mandate.” Laitram Corp. v. NEC Corp., 115 F.3d 947, 951 (Fed. Cir. 1997).

IV. Analysis

The Secretary has not challenged prong three, which concerns timing. Tr. 112; Exhibit A at 5. Thus, the analysis concerns prongs one and two.

A. Althen Prong One The Court’s Opinion and Order directed the undersigned to evaluate whether Mr. Hoffman presented “preponderant evidence linking the flu vaccine to CIDP via a biologically plausible theory.” The Court also defined “plausibility” in terms of being “conceivably true.” The theory that Mr. Hoffman advances is molecular mimicry. Thus, by substitution, the Court’s directive can be recast as requiring an evaluation as to whether preponderant evidence supports a finding that it is conceivably true that molecular mimicry can explain how the flu vaccine can cause CIDP.6 The parties agreed that the Opinion and Order may reasonably be interpreted as directing the undersigned to consider whether it is conceivable true that molecular mimicry can explain how the flu vaccine can cause CIDP. Tr. 112- 15.

Through Dr. Nadareishvili, Mr. Hoffman advances molecular mimicry as a biologically plausible way that a flu vaccine can cause CIDP. Pet’r’s Br. at 24-40; see also Exhibit 30 at 11.7 Any vaccine is designed to engage people’s immune systems. CIDP is considered an “immune-mediated neuropathy.” Exhibit 30 at 9. This means that a person’s immune system attacks components of the nervous system. A similar term is “autoimmune.” See Exhibit 32 (Lunn and Sheikh) at 768.8 Molecular mimicry is one of the most common theories offered by petitioners to explain how a vaccine can cause a disease. See Tr. 123. A list of more than 75 examples of cases with molecular mimicry is presented in the appendices.

In simple terms, the theory of molecular mimicry is a vaccine -> (activates) immune system -> (attacks) human tissue -> disease. Preponderant evidence supports a finding that this proposition is conceivably true in the context of flu vaccine and CIDP.

Evidence supporting the statement that it is conceivably true that molecular mimicry explains how the flu vaccine can cause CIDP comes primarily from the parties’ experts. Mr. Hoffman’s expert opined that “to a reasonable level of scientific probability, this patient's seasonal influenza vaccination formed a substantial factor in the development of inflammatory demyelinating polyradiculopathy, which eventually became chronic (CIDP).” Exhibit 30 at 7. Tr. 6 (identifying seven potentially relevant Federal Circuit precedential opinions). Under these circumstances, review of those opinions would not be appropriate.

The Secretary’s expert, Dr. Wilson, stated that “there is very weak evidence for any association between CIDP and influenza vaccinations.” Exhibit A at 4. Dr. Wilson did not opine that molecular mimicry is not conceivably true. Thus, to a degree, Dr. Wilson’s opinion is not answering the question posed by the Court.

Beyond the opinion of Dr. Nadareishvili, relatively little evidence strongly supports or strongly contradicts the proposition that it is conceivably true for molecular mimicry to explain how flu vaccine can cause CIDP. For example, Dr. Nadareishvili cited two articles in which the authors surveyed approximately 100 people who had CIDP to determine what were antecedent events. Exhibit 30 at 8 n.3. In one article, four people reported receiving vaccines but none reported the flu vaccine. Exhibit 55 (McCombe) at 2622. 9 In the second article, none of the people reported a vaccination within six weeks before the onset of their CIDP, although 16 people reported an infection. Exhibit 56 (Bouchard) at 499. 10 At oral argument, Mr. Hoffman’s counsel maintained that McCombe was relevant because the authors “include vaccines in their data set.” Tr. 146. 11

It would be difficult to find that McCombe or Bouchard make it likely that flu vaccination causes CIDP. See Howard v. Sec’y of Health & Hum. Servs., No. 16-1592V, 2022 WL 4869354, at *11, *24-25 (Fed. Cl. Spec. Mstr. Aug. 31, 2022) (denying entitlement despite the presence of McCombe), mot. for rev. denied, 2023 WL 4117370, at *6 (Fed. Cl. 2023), aff’d without opinion, 2024 WL 2873301 (Fed. Cir. 2024). But, when the operative issue is whether it is conceivably true that flu vaccination can cause CIDP via molecular mimicry, then McCombe and Bouchard are supportive.

The same analysis also deepens the evidentiary value of a case report Dr. Nadareishvili advanced. In this article, the authors described an instance in which a 74-year-old man received a flu vaccination and, two days later, developed weakness that led to a diagnosis of CIDP. Exhibit 44 (Brostoff) at 229. 12 Generally speaking, case reports provide little, if any, persuasive evidence that an antecedent event (like a vaccination) caused the subsequence evident (like a disease) because the case reports present sequences of events. 13 See Tr. 152-54. But, the present inquiry is different: does a case report enhance the biologic plausibility of the proposition? It does. See J. v. Sec’y of Health & Hum. Servs., 155 Fed. Cl. 20, 47 (2021) (characterizing the Agmon-Levin case reports as “probative”); Bryan v. Sec’y of Health & Hum. Servs., No. 14-898V, 2020 WL 7089841, at *21 (Fed. Cl. Spec. Mstr. Oct. 9, 2020). The authors’ creation of a case report supports the idea that it is “conceivably true” that the preceding event caused the subsequent event. See Tr. 154.

Under the “biological plausibility” / “conceivably true” standard, Mr. Hoffman has passed this threshold with Dr. Nadareishvili’s invocation of molecular mimicry as a method to explain how flu vaccine can cause CIDP. It also seems that almost every offering of molecular mimicry would be seen as conceivably true. The appendices demonstrate the variety of vaccine-injury combinations in which petitioners have proposed molecular mimicry. In a non- binding opinion, a different judge recognized the molecular mimicry could encompass almost anything:

In fact, because Dr. Tornatore does not offer any specific explanation as to the distinct connection between Tdap, molecular mimicry, and GBS, one could take Dr. Tornatore’s causation theory and substitute any table vaccine (e.g., the measles vaccine) and any autoimmune disorder (e.g., autoimmune encephalitis) and Dr. Tornatore’s expert report’s discussion of molecular mimicry would require absolutely no changes. That is how general his molecular mimicry theory is—it does not matter which vaccine and which autoimmune disorder are plugged in.

Dennington v. Sec’y of Health & Hum. Servs., 167 Fed. Cl. 640, 654 (2023), appeal dismissed, No. 2024-1214 (Fed. Cir. Mar. 25, 2024) When asked at oral argument what evidence would negate the plausibility of molecular mimicry, Mr. Hoffman’s counsel struggled to articulate any. See Tr. 174. Mr. Hoffman’s attorney argued that “there will never be a point where the – where the Special Masters are in a position to negate molecular mimicry.” Tr. 167. 14

The outcome of this ruling differs from the outcome in the First Entitlement Decision because the burden of proof has changed. The First Entitlement Decision found that Mr. Hoffman did not present a persuasive medical theory. However, for the reasons explained above, Mr. Hoffman has presented a plausible medical theory.

Accordingly, Mr. Hoffman has met the burden of proof as the Court has defined it for Althen prong one.

B. Althen Prong Two The second element of the causation-in-fact test is whether petitioner has shown “a logical sequence of cause and effect showing that the vaccination was the reason for the injury.” Althen, 418 F.3d at 1278. With respect to this prong, the Federal Circuit has instructed special masters to consider carefully the views of a treating doctor. Capizzano v. Sec’y of Health & Hum. Servs., 440 F.3d 1317, 1326 (Fed. Cir. 2006).

Here, Mr. Hoffman draws support from Dr. Nadareishvili, who opined that the vaccination was “a substantial factor in the causation of Mr. Hoffman’s injured condition.” Exhibit 30 at 1. Dr. Nadareishvili appears to reach this conclusion because (1) in his view, the flu vaccine can cause CIDP, (2) the CIDP presented in an appropriate time after the flu vaccination (12 days), and (3) an elimination of other potential causes. See id. at 18. Mr. Hoffman reasons this way as well. Pet’r’s Br. at 41-43; Tr. 184-87.

Whether other causes of CIDP have been eliminated is debatable. The Secretary’s expert, Dr. Wilson, stated that CLL has been associated with CIDP. Exhibit A at 4. But, Dr. Wilson confirmed with admirable honesty and clarity in his second report: “I did not provide a mechanistic explanation for what causes CIDP; however, I intentionally did not use the words ‘cause’ or ‘causal’ when discussing the association between hematologic malignancies and CIDP. No one knows what triggers CIDP.” Exhibit C at 2. The Secretary similarly conceded that the Secretary has not explained how a cancer can cause CIDP. Tr. 193-94.15 Thus, Mr. Hoffman’s experience of CLL four years earlier still allows for a finding that the flu vaccine caused his CIDP. See Pet’r’s Supp’l Br., filed July 24, 2024, at 7- 10.

At the end of the day, relatively little evidence supports or detracts on this point. See Exhibit 30 at 18 (Dr. Nadareishvili: “Regarding the opinions of treating physicians on etiology, the record in this case is relatively quiet”). The scarcity of evidence does not prevent a finding in Mr. Hoffman’s favor as the proverbial evidentiary scales need to tip only slightly. There is sufficient evidence for Mr. Hoffman to meet his burden.

V. Conclusion

Under the standards set in the Court’s Opinion and Order, Mr. Hoffman has shown that he is entitled to compensation. A separate damages order will issue shortly.

The Clerk’s Office is directed to provide this Ruling to the assigned judge. See Vaccine Rule 28.1(a).

IT IS SO ORDERED. s/Christian J. Moran Christian J. Moran Special Master

2019 WL rheumatoid Parker Sanders, SM. 14‐979V 6/24/2019 flu accepted

3425297 arthritis 2019 WL

McKown Corcoran, SM. 15‐1451V 7/15/2019 HPV POTS rejected

4072113 2019 WL transverse Pearson Dorsey, SM. 16‐9V 7/31/2019 flu rejected

3852633 myelitis

SM was not arbitrary or

146 Fed. Cl. capricious in

Yalacki Firestone, J. 14‐278V 8/5/2019 hepatitis B POTS, CFS rejected

80 rejecting molecular mimicry

2019 WL small fiber

Swaiss Gowen, SM. 15‐286V 11/4/2019 Tdap accepted

6520791 GBS

MFR denied,

2019 WL rheumatoid

Tullio Moran, SM. 15‐51V 12/19/2019 flu rejected 149 Fed.

7580149 arthritis

Cl. 448 (2020)

2020 WL multiple

Hitt Moran, SM. 15‐1283V 1/24/2020 flu accepted

831822 sclerosis

GBS as diagnosis 2020 WL

Sweeney Sanders, SM. 13‐392V 2/28/2020 flu GBS not evaluated was not

1844672 established Respondent's expert offered MM to explain para‐ how lung cancer

2020 WL

Sweeney Sanders, SM. 13‐392V 2/28/2020 flu neoplastic accepted could have

1844672 syndrome neurologic complications. SM seemed to endorse.

2020 WL

Allard Roth, SM. 14‐442V 3/9/2020 HPV ITP rejected

1649669 2020 WL Timing was Rowan Corcoran, SM. 17‐760V 4/28/2020 flu GBS not evaluated

2954954 wrong

MFR denied,

2020 WL MMR and Onset was too

Castaneda Oler, SM. 15‐1066V 5/18/2020 PANS rejected 152

3833076 others quick

Fed.Cl. 576 (2020) MFR flu and/or denied,

2020 WL cryoglobuline

Temes Corcoran, SM. 16‐1465V 5/21/2020 pneumoco rejected 151 Fed.

4198036 mia ccal Cl. 448

(2020) 2020 WL

Walls Olers, SM. 16‐557V 6/23/2020 childhood ITP accepted

13801342 2020 WL pneumoco

Deshler Corcoran, SM. 16‐1070V 7/1/2020 GBS rejected

4593162 ccal

MFR denied,

2020 WL

Duncan Moran, SM. 16‐1367V 10/19/2020 HPV PANDAS rejected 153 Fed.

6738118

Cl. 642 (2021)

Petition filed

Soltero 2020 WL

Horner, SM. 16‐808V 10/20/2020 flu GBS accepted before Table Arias 6706071 change

MFR denied,

2020 WL

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu narcolepsy rejected 154

9076620

Fed.Cl. 149 (2021) MFR denied,

2020 WL small fiber

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu rejected 154

9076620 neuropathy

Fed.Cl. 149 (2021) MFR denied,

2020 WL

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu CFS rejected 154

9076620

Fed.Cl. 149 (2021) MFR denied,

2020 WL

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu POTS rejected 154

9076620

Fed.Cl. 149 (2021)

2020 WL

Phillips Oler, SM. 16‐906V 11/23/2020 HPV ITP accepted

7767511 2020 WL

Phillips Oler, SM. 16‐906V 11/23/2020 live flu ITP rejected

7767511

Special master's rejection of flu and/or molecular

151 Fed. Cl. cryoglobuline

Temes Griggsby, J. 16‐1465V 12/7/2020 pneumoco rejected mimicry was

448 mia ccal supported by substantial evidence.

2021 WL

Pickens Moran, SM. 17‐187V 1/22/2021 MMR SIDP rejected

615218

Special master found that

2021 WL polyneuropat

Blender Dorsey, SM. 16‐1308V 2/26/2021 flu accepted pneumococcal

1096662 hy vaccine played no role primary

2021 WL medistinal

Nifakos Oler, SM. 14‐236V 3/4/2021 HPV rejected

1345218 large B‐cell lymphoma Thrombotic

2021 WL

Parmer Roth, SM. 16‐880V 3/25/2021 flu Thrombo‐ accepted

1524512 cytopenia 2021 WL multiple

Robinson Oler, SM. 14‐952V 4/12/2021 flu accepted

2371721 sclerosis

SM was not arbitrary or

153 Fed. Cl. capricious in

Duncan Davis, J. 16‐1367V 4/19/2021 HPV PANDAS rejected

642 rejecting molecular mimicry vacated On review, CFC and found that remanded,

2021 WL brachial

Patton Horner, SM. 15‐1553V 5/17/2021 flu rejected molecular 157

2389835 neuritis mimicry theory Fed.Cl. satisfied Althen 1 159

(2021). SM was not

MFR arbitrary or denied, affirmed, 2021 WL pneumoco capricious in

Loyd Corcoran, SM. 16‐811V 5/20/2021 ITP rejected not 2023 WL

2708941 ccal rejecting available 1878572 molecular on WL mimicry

2021 WL small fiber

E.M. Sanders, SM. 14‐753V 7/9/2021 flu accepted

3477837 neuropathy

MFR denied,

2021 WL

Caredio Corcoran, SM. 17‐79V 7/30/2021 flu epilepsy rejected 2021 WL

4100294

6058835 (2021)

Accepted theory in ruling but later dismissed for insufficient premature

2021 WL evidence that Brayboy Sanders, SM. 15‐183V 8/30/2021 HPV ovarian accepted

4453146 Petitioner has insufficiency

POI with autoimmune etiology, 2022 WL 1316235

2021 WL rheumatoid

Moran Oler, SM. 16‐538V 10/4/2021 flu rejected

4853544 arthritis 2021 WL pneumoco Miller‐Fisher

Koller Gowen, SM. 16‐439V 10/8/2021 accepted

5027947 ccal GBS 2021 WL

Andrews Oler, SM. 16‐196V 10/21/2021 flu SLE rejected

5755328 2021 WL peripheral Haubner Sanders, SM. 16‐1426V 10/22/2021 flu rejected

5614942 neuropathy

Petitioner did not 2021 WL

Winkler Dorsey, SM. 18‐203V 12/10/2021 Tdap GBS not evaluated establish other

6276203

Althen prongs 2021 WL accepted in

Berg Oler, SM. 16‐650V 12/14/2021 flu CIDP

6883495 dicta 2022 WL transverse

I.J. Corcoran, SM. 16‐864V 1/4/2022 Tdap accepted Ruling on remand

277555 myelitis juvenile 2022 WL

Putman Corcoran, SM. 19‐1921V 1/31/2022 MMR idiopathic rejected

600417 arthritis 2022 WL

Mason Corcoran, SM. 17‐1383V 2/4/2022 flu CIDP accepted

600415 2022 WL

Clark Horner, SM. 18‐813V 2/7/2022 hepatitis B shoulder rejected

16635681 2022 WL

Sanchez Corcoran, SM. 18‐1012V 3/11/2022 Tdap CIDP rejected

1013264 2022 WL pneumoco Maloney Dorsey, SM. 19‐1713V 3/17/2022 GBS accepted

1074087 ccal 2022 WL pneumoco transverse Tracy Sanders, SM. 16‐213V 3/30/2022 accepted

1125281 ccal myelitis

MFR denied, affirmed, 2022 WL

K.A. Corcoran, SM. 16‐989V 4/18/2022 Tdap GBS rejected 164 2024 WL

20213037

Fed.Cl. 98 2012526 (2022)

2022 WL pneumoco ulcerative

Gapen Moran, SM. 19‐422V 5/5/2022 rejected

1711616 ccal colitis

MMR, 2022 WL varicella,

Moses Moran, SM. 19‐739V 5/18/2022 sJIA rejected

2073346 pneumoco ccal

MFR Petitioner did not denied, affirmed, 2022 WL

Henkel Sanders, SM. 15‐1048V 8/31/2022 live flu narcolepsy accepted establish other 165 2024 WL

16557979

Althen prongs Fed.Cl. 3873569

153 (2023) 2022 WL small fiber

J.D. Sanders, SM. 14‐742V 8/31/2022 flu rejected

16543853 neuropathy 2022 WL pneumoco

Gross Dorsey, SM. 17‐1075V 9/22/2022 CIDP accepted

9669651 ccal 2023 WL

Mitchell Dorsey, SM. 19‐1534V 1/11/2023 flu ITP accepted

4483134 2023 WL

C.F Horner, SM. 15‐731V 1/20/2023 HPV POTS rejected

2198809 2023 WL

E.A. Dorsey, SM. 18‐1587V 1/24/2023 flu Bell's palsy accepted

2640710 2023 WL

Bishara Moran, SM. 19‐115V 1/27/2023 Tdap scleroderma rejected

2799054

SM was not arbitrary or

164 Fed. Cl. hepatitis B, capricious in affirmed J.S. Meyers, J. 16‐1083V 2/13/2023 POTS rejected

314 HPV rejecting 9/5/24 molecular mimicry

MFR denied,

2023 WL pneumoco

Trollinger Corcoran, SM. 16‐473V 2/17/2023 GBS rejected 167

2521912 ccal

Fed.Cl. 127 (2023)

2023 WL

Radford Moran, SM. 18‐704V 2/22/2023 flu CIDP rejected

2159306 auto‐immune 2023 WL autonomic

Ambriz Sanders, SM. 15‐502V 2/27/2023 HPV rejected

2771037 ganglionopat hy

MFR premature Denied denied,

2023 WL

Bello Sanders, SM. 13‐349V 3/10/2023 HPV ovarian accepted entitlement on 167

2447497 failure other prongs Fed.Cl.

517 (2023) 2023 WL transverse

Le Dorsey, SM. 16‐1078V 3/30/2023 Tdap accepted

3049203 myelitis Giannanto 2023 WL

Moran, SM. 18‐497V 3/30/2023 varicella ADEM rejected nio 2721387

2023 WL J.G. Dorsey, SM. 20‐664V 4/3/2023 hepatitis A GBS accepted

2752634 2023 WL

Specks Sanders, SM. 15‐491V 4/14/2023 flu POTS rejected

2947619 2023 WL

DrummondSanders, SM. 16‐702V 4/21/2023 HPV POTS rejected

3035072 2023 WL myasthenia Kelly Horner, SM. 16‐1548V 5/5/2023 flu rejected

3274159 gravis 2023 WL myasthenia

Smilo Dorsey, SM. 18‐1585V 5/15/2023 flu rejected

3918397 gravis 2023 WL multiple

Bravo Moran, SM. 17‐501V 5/31/2023 hepatitis B rejected

4147146 sclerosis 2023 WL

Hofer Gowen, SM. 18‐1752V 6/12/2023 flu MAID accepted

4397810 2023 WL rheumatoid Clark Oler, SM. 17‐1553V 6/16/2023 flu rejected

4897284 arthritis 2023 WL dermato‐

McDaniel Dorsey, SM. 17‐1322V 6/26/2023 flu rejected

4678688 myositis 2023 WL small fiber

Schlusser Sanders, SM. 16‐901V 6/30/2023 flu rejected

4926908 neuropathy 2023 WL

Osso Dorsey, SM. 18‐575V 7/13/2023 hepatitis B GBS accepted

5016473 2023 WL hepatitis A multiple Williams Roth, SM. 13‐471V 7/25/2023 accepted

4741993 &B sclerosis 2023 WL multiple

Mathis Moran, SM. 20‐431V 8/1/2023 flu rejected

5436135 sclerosis 2023 WL

Cobb Oler, SM. 17‐1123V 8/21/2023 HPV narcolepsy accepted

6457568

MFR denied,

2023 WL multiple appeal

Townsend Dorsey, SM. 14‐266V 8/29/2023 flu rejected 170

6212496 sclerosis filed

Fed.Cl. 130 (2024)

2023 WL transverse

Bowling Moran, SM. 18‐109V 9/20/2023 flu rejected

6846491 myelitis 2023 WL alopecia

Farag Sanders, SM. 17‐714V 9/29/2023 HPV rejected

7203034 areata 167 Fed. Cl.

DenningtonSomers, J. 18‐1303V 10/6/2023 tetanus GBS rejected chronic 2023 WL

Stoev Moran, SM. 19‐1434V 10/12/2023 HPV regional pain rejected

7297981 syndrome Arredond 2023 WL

Dorsey, SM. 18‐1782V 10/31/2023 flu Bell's palsy accepted o 8181138

2023 WL small fiber Fiske Oler, SM. 17‐1378V 11/13/2023 flu accepted

8352761 neuropathy 2023 WL pneumoco

Sprenger Dorsey, SM. 18‐279V 11/14/2023 GBS accepted

8543435 ccal 2023 WL rheumatoid Wilson Oler, SM. 17‐1264V 12/7/2023 flu rejected

9053671 arthritis 2024 WL small fiber

Greenhaw Moran, SM. 21‐2032V 1/2/2024 flu rejected

263123 neuropathy mot. for systemic rev.

2024 WL lupus denied,

Stricker Moran, SM. 18‐56V 1/2/2024 HPV rejected

263189 erthematosu 170 s (SLE) Fed.Cl.

701 (2024) 2024 WL pneumoco

Anderson Dorsey, SM. 18‐484V 1/17/2024 GBS accepted

557052 ccal 2024 WL

Alsaadeh Dorsey, SM. 19‐1097V 1/23/2024 flu hearing loss rejected

694072 2024 WL

Rocha Moran, SM. 16‐241V 2/1/2024 hepatitis B vasculitis rejected

752787

MFR denied,

Gamboa‐ 2023 WL pneumoco appeal

Tapp, J. 18‐925V 2/26/2024 GBS rejected 170 Avila 6536207 ccal filed

Fed.Cl. 441 (2024) MFR sensori‐

2024 WL denied, Herms Dorsey, SM. 19‐70V 3/4/2024 DTaP neural rejected

1340669 2024 WL hearing loss

3837327 2024 WL

Sparrow Moran, SM. 18‐295V 3/19/2024 MMR ADEM rejected MFR filed

1599165

Petitioner did not 2024 WL transverse

Brancheau Dorsey, SM. 21‐1209V 3/21/2024 flu not evaluated establish other

1619606 myelitis

Althen prongs 2024 WL GBS ‐ non‐

Lau Dorsey, SM. 19‐1956V 3/22/2024 flu accepted

1638367 Table 2024 WL Anti‐NMDAR

L.R. / BaxteOler, SM. 16‐922V 3/28/2024 various rejected

1912575 encephalitis 2024 WL small fiber

Coons Dorsey, SM. 20‐1067V 3/29/2024 Td accepted

1741619 neuropathy 2024 WL

Broussard Moran, SM. 18‐302V 4/4/2024 hepatitis B NMO rejected

1829210

Petitioner did not 2024 WL neuroinflama have

M.M. Dorsey, SM. 18‐583V 7/18/2024 flu not evaluated

4164557 mation neuroinflammati on 2024 WL pneumoco

Morrison Oler, SM. 18‐386V 7/18/2024 GBS rejected

3738934 ccal Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review 2020 WL

Walls Olers, SM. 16‐557V 6/23/2020 childhood ITP accepted

13801342

MFR sensori‐

2024 WL denied, Herms Dorsey, SM. 19‐70V 3/4/2024 DTaP neural rejected

1340669 2024 WL hearing loss

3837327 2021 WL peripheral

Haubner Sanders, SM. 16‐1426V 10/22/2021 flu rejected

5614942 neuropathy 2023 WL

E.A. Dorsey, SM. 18‐1587V 1/24/2023 flu Bell's palsy accepted

2640710 Arredond 2023 WL

Dorsey, SM. 18‐1782V 10/31/2023 flu Bell's palsy accepted o 8181138 vacated On review, CFC and found that remanded,

2021 WL brachial

Patton Horner, SM. 15‐1553V 5/17/2021 flu rejected molecular 157

2389835 neuritis mimicry theory Fed.Cl. satisfied Althen 1 159

(2021). 2021 WL accepted in

Berg Oler, SM. 16‐650V 12/14/2021 flu CIDP

6883495 dicta 2022 WL

Mason Corcoran, SM. 17‐1383V 2/4/2022 flu CIDP accepted

600415 2023 WL

Radford Moran, SM. 18‐704V 2/22/2023 flu CIDP rejected

2159306 2023 WL dermato‐ McDaniel Dorsey, SM. 17‐1322V 6/26/2023 flu rejected

4678688 myositis

MFR denied,

2021 WL

Caredio Corcoran, SM. 17‐79V 7/30/2021 flu epilepsy rejected 2021 WL

4100294

6058835 (2021)

Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review GBS as diagnosis

2020 WL

Sweeney Sanders, SM. 13‐392V 2/28/2020 flu GBS not evaluated was not

1844672 established 2020 WL Timing was

Rowan Corcoran, SM. 17‐760V 4/28/2020 flu GBS not evaluated

2954954 wrong

Petition filed Soltero 2020 WL

Horner, SM. 16‐808V 10/20/2020 flu GBS accepted before Table Arias 6706071 change 2024 WL GBS ‐ non‐

Lau Dorsey, SM. 19‐1956V 3/22/2024 flu accepted

1638367 Table 2024 WL

Alsaadeh Dorsey, SM. 19‐1097V 1/23/2024 flu hearing loss rejected

694072 2023 WL

Mitchell Dorsey, SM. 19‐1534V 1/11/2023 flu ITP accepted

4483134 2023 WL

Hofer Gowen, SM. 18‐1752V 6/12/2023 flu MAID accepted

4397810 2020 WL multiple Hitt Moran, SM. 15‐1283V 1/24/2020 flu accepted

831822 sclerosis 2021 WL multiple

Robinson Oler, SM. 14‐952V 4/12/2021 flu accepted

2371721 sclerosis 2023 WL multiple

Mathis Moran, SM. 20‐431V 8/1/2023 flu rejected

5436135 sclerosis

MFR denied,

2023 WL multiple appeal

Townsend Dorsey, SM. 14‐266V 8/29/2023 flu rejected 170

6212496 sclerosis filed

Fed.Cl. 130 (2024)

2023 WL myasthenia

Kelly Horner, SM. 16‐1548V 5/5/2023 flu rejected

3274159 gravis 2023 WL myasthenia

Smilo Dorsey, SM. 18‐1585V 5/15/2023 flu rejected

3918397 gravis Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review Petitioner did not

2024 WL neuroinflama have

M.M. Dorsey, SM. 18‐583V 7/18/2024 flu not evaluated

4164557 mation neuroinflammati on Respondent's expert offered MM to explain para‐ how lung cancer

2020 WL

Sweeney Sanders, SM. 13‐392V 2/28/2020 flu neoplastic accepted could have

1844672 syndrome neurologic complications. SM seemed to endorse. Special master found that

2021 WL polyneuropat

Blender Dorsey, SM. 16‐1308V 2/26/2021 flu accepted pneumococcal

1096662 hy vaccine played no role

2023 WL

Specks Sanders, SM. 15‐491V 4/14/2023 flu POTS rejected

2947619 2019 WL rheumatoid Parker Sanders, SM. 14‐979V 6/24/2019 flu accepted

3425297 arthritis

MFR denied,

2019 WL rheumatoid

Tullio Moran, SM. 15‐51V 12/19/2019 flu rejected 149 Fed.

7580149 arthritis

Cl. 448 (2020)

2021 WL rheumatoid

Moran Oler, SM. 16‐538V 10/4/2021 flu rejected

4853544 arthritis 2023 WL rheumatoid

Clark Oler, SM. 17‐1553V 6/16/2023 flu rejected

4897284 arthritis Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review 2023 WL rheumatoid

Wilson Oler, SM. 17‐1264V 12/7/2023 flu rejected

9053671 arthritis 2021 WL

Andrews Oler, SM. 16‐196V 10/21/2021 flu SLE rejected

5755328 2023 WL small fiber Fiske Oler, SM. 17‐1378V 11/13/2023 flu accepted

8352761 neuropathy 2024 WL small fiber

Greenhaw Moran, SM. 21‐2032V 1/2/2024 flu rejected

263123 neuropathy 2021 WL small fiber

E.M. Sanders, SM. 14‐753V 7/9/2021 flu accepted

3477837 neuropathy 2022 WL small fiber

J.D. Sanders, SM. 14‐742V 8/31/2022 flu rejected

16543853 neuropathy 2023 WL small fiber

Schlusser Sanders, SM. 16‐901V 6/30/2023 flu rejected

4926908 neuropathy

Thrombotic 2021 WL

Parmer Roth, SM. 16‐880V 3/25/2021 flu Thrombo‐ accepted

1524512 cytopenia 2019 WL transverse

Pearson Dorsey, SM. 16‐9V 7/31/2019 flu rejected

3852633 myelitis 2023 WL transverse

Bowling Moran, SM. 18‐109V 9/20/2023 flu rejected

6846491 myelitis

Petitioner did not 2024 WL transverse

Brancheau Dorsey, SM. 21‐1209V 3/21/2024 flu not evaluated establish other

1619606 myelitis

Althen prongs

MFR flu and/or denied,

2020 WL cryoglobuline

Temes Corcoran, SM. 16‐1465V 5/21/2020 pneumoco rejected 151 Fed.

4198036 mia ccal Cl. 448

(2020) Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review Special master's rejection of flu and/or molecular

151 Fed. Cl. cryoglobuline

Temes Griggsby, J. 16‐1465V 12/7/2020 pneumoco rejected mimicry was

448 mia ccal supported by substantial evidence.

2023 WL

J.G. Dorsey, SM. 20‐664V 4/3/2023 hepatitis A GBS accepted

2752634 2023 WL hepatitis A multiple Williams Roth, SM. 13‐471V 7/25/2023 accepted

4741993 &B sclerosis 2023 WL

Osso Dorsey, SM. 18‐575V 7/13/2023 hepatitis B GBS accepted

5016473 2023 WL multiple Bravo Moran, SM. 17‐501V 5/31/2023 hepatitis B rejected

4147146 sclerosis 2024 WL

Broussard Moran, SM. 18‐302V 4/4/2024 hepatitis B NMO rejected

1829210

SM was not arbitrary or

146 Fed. Cl. capricious in

Yalacki Firestone, J. 14‐278V 8/5/2019 hepatitis B POTS, CFS rejected

80 rejecting molecular mimicry

2022 WL

Clark Horner, SM. 18‐813V 2/7/2022 hepatitis B shoulder rejected

16635681 2024 WL

Rocha Moran, SM. 16‐241V 2/1/2024 hepatitis B vasculitis rejected

752787 Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review SM was not arbitrary or

164 Fed. Cl. hepatitis B, capricious in affirmed J.S. Meyers, J. 16‐1083V 2/13/2023 POTS rejected

314 HPV rejecting 9/5/24 molecular mimicry

2023 WL alopecia

Farag Sanders, SM. 17‐714V 9/29/2023 HPV rejected

7203034 areata auto‐immune 2023 WL autonomic

Ambriz Sanders, SM. 15‐502V 2/27/2023 HPV rejected

2771037 ganglionopat hy chronic

2023 WL

Stoev Moran, SM. 19‐1434V 10/12/2023 HPV regional pain rejected

7297981 syndrome 2020 WL

Allard Roth, SM. 14‐442V 3/9/2020 HPV ITP rejected

1649669 2020 WL

Phillips Oler, SM. 16‐906V 11/23/2020 HPV ITP accepted

7767511 2023 WL

Cobb Oler, SM. 17‐1123V 8/21/2023 HPV narcolepsy accepted

6457568

MFR denied,

2020 WL

Duncan Moran, SM. 16‐1367V 10/19/2020 HPV PANDAS rejected 153 Fed.

6738118

Cl. 642 (2021)

Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review SM was not arbitrary or

153 Fed. Cl. capricious in

Duncan Davis, J. 16‐1367V 4/19/2021 HPV PANDAS rejected

642 rejecting molecular mimicry

2019 WL

McKown Corcoran, SM. 15‐1451V 7/15/2019 HPV POTS rejected

4072113 2023 WL

C.F Horner, SM. 15‐731V 1/20/2023 HPV POTS rejected

2198809 2023 WL

DrummondSanders, SM. 16‐702V 4/21/2023 HPV POTS rejected

3035072

MFR premature Denied denied,

2023 WL

Bello Sanders, SM. 13‐349V 3/10/2023 HPV ovarian accepted entitlement on 167

2447497 failure other prongs Fed.Cl.

517 (2023) Accepted theory in ruling but later dismissed for insufficient premature

2021 WL evidence that Brayboy Sanders, SM. 15‐183V 8/30/2021 HPV ovarian accepted

4453146 Petitioner has insufficiency

POI with autoimmune etiology, 2022 WL 1316235 primary

2021 WL medistinal

Nifakos Oler, SM. 14‐236V 3/4/2021 HPV rejected

1345218 large B‐cell lymphoma Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review mot. for systemic rev.

2024 WL lupus denied,

Stricker Moran, SM. 18‐56V 1/2/2024 HPV rejected

263189 erthematosu 170 s (SLE) Fed.Cl.

701 (2024) MFR denied,

2020 WL

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu CFS rejected 154

9076620

Fed.Cl. 149 (2021) MFR denied,

2020 WL

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu narcolepsy rejected 154

9076620

Fed.Cl. 149 (2021) MFR denied,

2020 WL

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu POTS rejected 154

9076620

Fed.Cl. 149 (2021) MFR denied,

2020 WL small fiber

E.S. Corcoran, SM. 17‐480V 11/13/2020 HPV, flu rejected 154

9076620 neuropathy

Fed.Cl. 149 (2021)

Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review 2020 WL

Phillips Oler, SM. 16‐906V 11/23/2020 live flu ITP rejected

7767511

MFR Petitioner did not denied, affirmed, 2022 WL

Henkel Sanders, SM. 15‐1048V 8/31/2022 live flu narcolepsy accepted establish other 165 2024 WL

16557979

Althen prongs Fed.Cl. 3873569

153 (2023) 2024 WL

Sparrow Moran, SM. 18‐295V 3/19/2024 MMR ADEM rejected MFR filed

1599165 juvenile 2022 WL

Putman Corcoran, SM. 19‐1921V 1/31/2022 MMR idiopathic rejected

600417 arthritis 2021 WL

Pickens Moran, SM. 17‐187V 1/22/2021 MMR SIDP rejected

615218

MFR denied,

2020 WL MMR and Onset was too

Castaneda Oler, SM. 15‐1066V 5/18/2020 PANS rejected 152

3833076 others quick

Fed.Cl. 576 (2020)

MMR,

2022 WL varicella,

Moses Moran, SM. 19‐739V 5/18/2022 sJIA rejected

2073346 pneumoco ccal 2022 WL pneumoco

Gross Dorsey, SM. 17‐1075V 9/22/2022 CIDP accepted

9669651 ccal 2020 WL pneumoco

Deshler Corcoran, SM. 16‐1070V 7/1/2020 GBS rejected

4593162 ccal 2022 WL pneumoco

Maloney Dorsey, SM. 19‐1713V 3/17/2022 GBS accepted

1074087 ccal Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review MFR denied,

2023 WL pneumoco

Trollinger Corcoran, SM. 16‐473V 2/17/2023 GBS rejected 167

2521912 ccal

Fed.Cl. 127 (2023)

2023 WL pneumoco

Sprenger Dorsey, SM. 18‐279V 11/14/2023 GBS accepted

8543435 ccal 2024 WL pneumoco

Anderson Dorsey, SM. 18‐484V 1/17/2024 GBS accepted

557052 ccal

MFR denied,

Gamboa‐ 2023 WL pneumoco appeal

Tapp, J. 18‐925V 2/26/2024 GBS rejected 170 Avila 6536207 ccal filed

Fed.Cl. 441 (2024)

2024 WL pneumoco

Morrison Oler, SM. 18‐386V 7/18/2024 GBS rejected

3738934 ccal

SM was not

MFR arbitrary or denied, affirmed, 2021 WL pneumoco capricious in

Loyd Corcoran, SM. 16‐811V 5/20/2021 ITP rejected not 2023 WL

2708941 ccal rejecting available 1878572 molecular on WL mimicry

2021 WL pneumoco Miller‐Fisher

Koller Gowen, SM. 16‐439V 10/8/2021 accepted

5027947 ccal GBS 2022 WL pneumoco transverse

Tracy Sanders, SM. 16‐213V 3/30/2022 accepted

1125281 ccal myelitis 2022 WL pneumoco ulcerative

Gapen Moran, SM. 19‐422V 5/5/2022 rejected

1711616 ccal colitis 2024 WL small fiber

Coons Dorsey, SM. 20‐1067V 3/29/2024 Td accepted

1741619 neuropathy Some Cases with Molecular Mimicry Sorted by Vaccine and then Injury

CoFC Fed. Cir. Title Judicial Officer Docket Date cite Vaccine Injury outcome notes review review 2022 WL

Sanchez Corcoran, SM. 18‐1012V 3/11/2022 Tdap CIDP rejected

1013264

Petitioner did not 2021 WL

Winkler Dorsey, SM. 18‐203V 12/10/2021 Tdap GBS not evaluated establish other

6276203

Althen prongs

MFR denied, affirmed, 2022 WL

K.A. Corcoran, SM. 16‐989V 4/18/2022 Tdap GBS rejected 164 2024 WL

20213037

Fed.Cl. 98 2012526 (2022)

2023 WL

Bishara Moran, SM. 19‐115V 1/27/2023 Tdap scleroderma rejected

2799054 2019 WL small fiber Swaiss Gowen, SM. 15‐286V 11/4/2019 Tdap accepted

6520791 GBS 2022 WL transverse

I.J. Corcoran, SM. 16‐864V 1/4/2022 Tdap accepted Ruling on remand

277555 myelitis 2023 WL transverse

Le Dorsey, SM. 16‐1078V 3/30/2023 Tdap accepted

3049203 myelitis 167 Fed. Cl.

DenningtonSomers, J. 18‐1303V 10/6/2023 tetanus GBS rejected Giannanto 2023 WL

Moran, SM. 18‐497V 3/30/2023 varicella ADEM rejected nio 2721387

2024 WL Anti‐NMDAR L.R. / BaxteOler, SM. 16‐922V 3/28/2024 various rejected

1912575 encephalitis